drugset / Trial / NCT01336647
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 2 study to assess the safety and effectiveness of a product to treat children and adults with head lice
Timeline
- Start
- 2011-04
- Primary completion
- 2011-08
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abametapir | Small molecule | 0.37 % | Topical |
| Subject | Abametapir | Small molecule | 0.74 % | Topical |